Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects

Song, Jinyoung

doi:10.4070/kcj.2022.0336

Cited by 5 publications

(6 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Transcatheter closure is especially considered in muscular VSD, because their surgical repair is still challenging due to right ventricular trabecularization and therefore difficult exploration of the defects [27]. Aneurysmatic perimembranous VSD are also suitable candidates as the AVP can be placed into the septal bulging.…”

Section: Discussionmentioning

confidence: 99%

“…Aneurysmatic perimembranous VSD are also suitable candidates as the AVP can be placed into the septal bulging. Other devices used for VSD closure are Amplatzer™ duct occluders and genuine VSD occluders, as, for example, the newly developed Lifetech™ Konar-MF or Amplatzer™ VSD occluders [27,28]. Compared to these devices, the advantage of AVP is their longer middle lobe that can fit in elongated, tunnel-like VSD.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs

Pfeifer,

Gheibeh,

Fries

et al. 2024

Cardiovascular Therapeutics

View full text Add to dashboard Cite

Objective: The objective of this study is to evaluate the clinical application and primary outcome of transcatheter embolization using Amplatzer™ Vascular Plug (AVP) Type 2 and Type 4 in different congenital cardiovascular malformations.Design: This is a single-center retrospective observational cohort study.Methods: We analyzed clinical and imaging data of 36 patients retrospectively who received transcatheter embolizations of the following malformations using AVP: systemic-to-pulmonary collateral arteries (SPCA), patent ductus arteriosus (PDA), ventricular septal defects (VSD), and aberrant pulmonary sequestration arteries (PSA). We included all patients treated in our institution from January 2010 to July 2023.Results: In 36 patients (median age 40.0 months, range 0.5 months–42.0 years; 56.8% male), 44 AVPs were implanted in 37 procedures. The target lesions were SPCA in n=15 procedures, PDA in n=9, VSD in n=9, and PSA in n=4. Thirty-four AVP Type 2 and 10 AVP Type 4 were applied, the latter only in SPCA and PSA. SPCA was most common in complex congenital heart disease with univentricular physiology (75.0%). VSD were associated with additional cardiac malformations in 33.3%, PDA were associated with prematurity (55.6%), and all pulmonary sequestrations occurred in scimitar syndrome. Primary total or subtotal occlusion succeeded in n38/44 (86.3%). For residual PDA, an additional occluder was implanted in one patient. In one case, pulmonary sequestration had to be treated surgically. One premature infant with PDA closure sustained a relevant obstruction of the left pulmonary artery by the outer AVP disc which required surgical correction 4 months later.Conclusion: Embolization using AVP is a suitable approach for closure of various cardiovascular malformations with a high primary success rate and low complication rate. It should be considered in treatment of different irregular vessel anomalies and in selected VSD.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs

Pfeifer,

Gheibeh,

Fries

et al. 2024

Cardiovascular Therapeutics

View full text Add to dashboard Cite

show abstract

“…Surgery for patients with perimembranous VSD is safe and effective at a young age [ 6 ]. The technique and device for transcatheter VSD have developed consistently [ 11 , 12 ]. The transcatheter technique is slightly complicated to perform and concerns about conduction problems, especially after membranous VSD closure with devices remain [ 6 , 12 ].…”

Section: Discussionmentioning

confidence: 99%

“…The technique and device for transcatheter VSD have developed consistently [ 11 , 12 ]. The transcatheter technique is slightly complicated to perform and concerns about conduction problems, especially after membranous VSD closure with devices remain [ 6 , 12 ]. Fluoroscopy and echocardiographic guidance are used [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

Demonstrating an Adult Ventricular Septal Defect Using Non-obstructive General Angioscopy

Komatsu¹,

Takahashi²,

Takewa³

et al. 2023

Cureus

View full text Add to dashboard Cite

A ventricular septal defect (VSD) is a common congenital heart disease, and the transcatheter technique for VSD requires practical guidance because it requires a complicated procedure. A non-obstructive angioscopy catheter system via the right ventricle successfully revealed an approximately 3-mm VSD with the shape of a rugby ball at the center of the white membranous septum of Kirklin type II in an older female with suspected coronary artery disease. A white membranous terraced septum was observed to be surrounded by a reddish ventricle. Conservative therapy was performed for her VSD because she did not meet the criteria for surgical treatment.

show abstract

“…Surgical closure has been accepted as a gold-standard treatment for perimembranous VSDs, but percutaneous transcatheter approach, mainly due to improvement in device design and materials, is emerging as an alternative novel option: this has been analyzed in a recent state-of-the-art review by Song,[ 12 ] who underlines the lower complete atrioventricular block incidence with newly developed soft devices, whereas proximity to the aortic and TVs remains one of the main challenges, especially in small patients, that is the reason why this procedure should only be performed by experienced teams and in specialized institutes after appropriate patient selection.…”

Section: Discussionmentioning

confidence: 99%